Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Vopratelimab |
Trade Name | |
Synonyms | JTX2011|JTX-2011 |
Drug Descriptions |
Vopratelimab (JTX-2011) is a humanized monoclonal antibody against ICOS (inducible co-stimulator molecule) that regulates anti-tumor immune response (Cancer Res 2016;76(14 Suppl):Abstract nr 573). |
DrugClasses | |
CAS Registry Number | 2039148-04-2 |
NCIT ID | C129876 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ipilimumab + Vopratelimab | Ipilimumab Vopratelimab | 0 | 2 |
Nivolumab + Vopratelimab | Nivolumab Vopratelimab | 0 | 2 |
Vopratelimab | Vopratelimab | 0 | 2 |